Literature DB >> 8862503

Transfection with the cDNA of the human thyrotropin receptor of a poorly differentiated rat thyroid cell line (FRT).

R Elisei1, A Pinchera, L Chiovato, C Mammoli, P Agretti, C Romei, F Santini, G Bendinelli, E Fiore, A Capaccioli, P Vitti.   

Abstract

A cell line derived from the Fisher rat thyroid (FRT), that does not have functional TSH receptor, was stably transfected with the cDNA of the human TSH receptor (h TSH-R). In wild FRT cells TSH (1-1000 mU/l) was unable to increase cAMP production, while 10-10000 nmol/l forskolin elicited a 10-30 fold cAMP stimulation. Two of the transfected clones were responsive to TSH in terms of cAMP production. In particular, the FRT-R3 transfected clone showed the highest sensitivity to the hormone with a 10 fold cAMP increase over the basal at 100 mU/l TSH. The Northern blot analysis using a 2.4 kbp cDNA probe for the hTSH-R showed a band corresponding to the mRNA of TSH receptor in FRT-R3 cells, but not in wild FRT cells. In both cell types TSH was ineffective in stimulating growth assayed by 3H-thymidine incorporation into DNA. Hybridization with a probe for thyroperoxidase on polymerase chain reaction products after reverse transcription of mRNA showed that FRT-R3, as well as FRT cells, do not have a transcript for thyroperoxidase. In conclusion, the data reported in this paper show that the insertion of the hTSH-R cDNA in the genome of poorly differentiated rat thyroid cells results in the recovery of TSH-dependent adenylate cyclase, but not other differentiated thyroid cell functions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8862503     DOI: 10.1007/BF03349873

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  26 in total

1.  Cell polarity and morphogenetic properties of Fischer rat thyroid cells (FRT) cultured in suspension or embedded in different gels.

Authors:  C Garbi; A Mascia; L Nitsch
Journal:  Cell Mol Biol       Date:  1987       Impact factor: 1.770

2.  Cyclic nucleotide metabolism in differentiated and undifferentiated epithelial thyroid cells in culture.

Authors:  E Mandato; R Catapano; F S Ambesi-Impiombato; V Macchia
Journal:  Biochim Biophys Acta       Date:  1981-08-05

3.  Incidence of antibodies blocking thyrotropin effect in vitro in patients with euthyroid or hypothyroid autoimmune thyroiditis.

Authors:  L Chiovato; P Vitti; F Santini; G Lopez; C Mammoli; P Bassi; L Giusti; M Tonacchera; G Fenzi; A Pinchera
Journal:  J Clin Endocrinol Metab       Date:  1990-07       Impact factor: 5.958

4.  Detection of antibodies blocking thyrotropin effect using Chinese hamster ovary cells transfected with the cloned human TSH receptor.

Authors:  L Chiovato; P Vitti; G Bendinelli; F Santini; E Fiore; A Capaccioli; M Tonacchera; C Mammoli; M Ludgate; A Pinchera
Journal:  J Endocrinol Invest       Date:  1994-11       Impact factor: 4.256

5.  Graves' IgG stimulation of continuously cultured rat thyroid cells: a sensitive and potentially useful clinical assay.

Authors:  P Vitti; W A Valente; F S Ambesi-Impiombato; G F Fenzi; A Pinchera; L D Kohn
Journal:  J Endocrinol Invest       Date:  1982 May-Jun       Impact factor: 4.256

6.  Graves' IgG stimulation of iodide uptake in FRTL-5 rat thyroid cells: a clinical assay complementing FRTL-5 assays measuring adenylate cyclase and growth-stimulating antibodies in autoimmune thyroid disease.

Authors:  C Marcocci; W A Valente; A Pinchera; S M Aloj; L D Kohn; E F Grollman
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

7.  Use of the recombinant human thyrotropin receptor (TSH-R) expressed in mammalian cell lines to assay TSH-R autoantibodies.

Authors:  M Ludgate; J Perret; M Parmentier; C Gerard; F Libert; J E Dumont; G Vassart
Journal:  Mol Cell Endocrinol       Date:  1990-10-01       Impact factor: 4.102

8.  Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assay.

Authors:  P Vitti; C M Rotella; W A Valente; J Cohen; S M Aloj; P Laccetti; F S Ambesi-Impiombato; E F Grollman; A Pinchera; R Toccafondi; L D Kohn
Journal:  J Clin Endocrinol Metab       Date:  1983-10       Impact factor: 5.958

9.  Antibodies that promote thyroid growth. A distinct population of thyroid-stimulating autoantibodies.

Authors:  W A Valente; P Vitti; C M Rotella; M M Vaughan; S M Aloj; E F Grollman; F S Ambesi-Impiombato; L D Kohn
Journal:  N Engl J Med       Date:  1983-10-27       Impact factor: 91.245

10.  Studies on the mechanism responsible for thyrotropin-induced expression of microsomal/peroxidase antigen in FRTL-5 cells.

Authors:  L Chiovato; P Vitti; A Lombardi; P Ceccarelli; P Cucchi; C Marcocci; P Carayon; A Pinchera
Journal:  Endocrinology       Date:  1988-08       Impact factor: 4.736

View more
  2 in total

Review 1.  Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer.

Authors:  Loredana Lorusso; Letizia Pieruzzi; Agnese Biagini; Elena Sabini; Laura Valerio; Carlotta Giani; Paolo Passannanti; Benedetta Pontillo-Contillo; Valentina Battaglia; Salvatore Mazzeo; Eleonora Molinaro; Rossella Elisei
Journal:  Onco Targets Ther       Date:  2016-10-20       Impact factor: 4.147

2.  Asynchrony of Apical Polarization, Luminogenesis, and Functional Differentiation in the Developing Thyroid Gland.

Authors:  Ellen Johansson; Shawn Liang; Carmen Moccia; Therese Carlsson; Daniel Andersson; Henrik Fagman; Mikael Nilsson
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-17       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.